Stroke Risk Reduction Alternative

The WATCHMAN™ Device demonstrated comparable stroke risk reduction, and statistically superior reductions in hemorrhagic stroke, disabling stroke and cardiovascular death compared to warfarin over long-term follow-up in the PROTECT AF Study1.